[PRC HOME]
 
University at Buffalo, the State University of New York School of Pharmacy and Pharmaceutical Sciences
 
Answers.com

 
  LCMSMS
Buprenorphine and Norbuprenorphine
Protease Inhibitor
Cortisol, Corticosteriods, Mycophenolic Acid and Mycophenolic Acid Glucuronide
Midazolam, Omeprazole and their Hydroxy Metabolites
Doxorubicin, Doxorubicinol, and Cyclophosphamide
Naltrexone and Naltrexol
Tenofovir

 

Buprenorphine and Norbuprenorphine

Simultaneous LCMSMS Method Buprenorphine and Norbuprenorphine

Analyte

Lower Limit of Quantitation
(mg/L)
Acceptable Anticoagulants Required PlasmaVolume CV% low QC

Buprenorphine

0.000250 EDTA Plasma (K)

Minimal 1 mL*

10

Norbuprenorphine

0.000250 8.8









Samples are prepared by solid phase extraction prior to chromatography. Deuterated internal standards are added to 0.5 mL of sample mixed with HCL solution prior to application onto a preconditioned Waters Oasis� MCX cartridge. The cartridge is rinsed with 5% methanol in 0.1N HCl. The samples are then eluted with 1% ammonium hydroxide in methanol and evaporated to dryness. The samples are reconstituted with a mix of mobile phase A and B. Forty percent of the reconstituted samples are injected in the LCMSMS system.

Samples are analyzed on a Agilent HPLC system coupled to a Sciex API3000 triple quadupole mass analyzer used in the positive MRM mode. A gradient chromatography method separates the compounds from other components on a Waters Symmetry� C18 column. Buprenorphine is detected using MS/MS pair 468/396; NBUP is detected as the protonated species only, 414.7.  A slow collection of ions at the detector allows for some gains in sensitivity.  Each sample analysis requires 6 minutes.

 

 


© 2005 ePharmacotherapy Networks. All rights reserved.
371 Cooke Hall - Buffalo, NY 14260-1200
Last Modified: Monday, 09-Jul-2007 17:06:31 EDT
Usage Statistics